|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 10, 2017 ) The Latin America Viral Inactivation Market was worth USD 42 million in 2016 and estimated to be growing at a CAGR of 11.2%, to reach USD 72 million by 2021. Viral Inactivation is the procedure of killing virus cells or making them inactive. This procedure is performed to prevent contamination of products by viruses and thereby increase the safety. Hence the viruses present in the final product are in inactive form. All these methods are used extensively in blood plasma and food industries to protect the products from viruses.
View full report @ http://www.marketdataforecast.com/market-reports/latin-america-viral-inactivation-market-3233/
Among the many methods which are used in inactivation of viruses are irradiation by UV rays, solvent/detergent usage, dry heating, pasteurization, and lowering of pH among others. Pasteurization is a useful only when the viruses are less resistant than the proteins to be protected. Viral Inactivation by solvents and detergents is the most widely used method in the blood plasma industry, effective only when viruses are encapsulated in lipid molecules. The detergents/solvents irritate the lipid layers and kill the viruses since they cannot survive without lipid molecules. UV radiations kill the viruses by dimerising nucleic acids, thus affecting their life cycle and reproduction processes. pH lowering is useful only when the molecules in the final product are more resistant than viruses.
Some of the driving forces of Latin America Viral Inactivation market are attention of research and development industries in life sciences, increasing support of government in biotechnology and pharmaceuticals sectors, growing incidence of chronic diseases, rising support of government in biotechnology and pharmaceuticals sectors and launch of new drugs among others. The constraints that this market is facing are presence of strong consolidation and less number of skilled workers.
The Latin America Viral Inactivation market is segmented on the basis of method, product, application and end-user. Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light. The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses. Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment. Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others.
Download free sample @ http://www.marketdataforecast.com/market-reports/latin-america-viral-inactivation-market-3233/request-sample
The Latin America market for Viral Inactivation is geographically segmented into Brazil, Argentina, Chile and rest of Latin America. The market in this region is still in its nascent stages. Factors such as introduction of new drugs, increasing patients with chronic diseases and growing support of government in biotechnology and pharmaceuticals sectors are presumed to propel the growth of this market in the region.
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc
Market Segmentation
1) Method
Solvent/Detergent Method
Pasteurization
UV Radiation
Microwave Heating
High-Energy Light
Y-o-Y Growth Analysis, By Method
Market Attractiveness Analysis, By Method
Market Share Analysis, By Method
2) Product
Kits and Reagents
Services
Accesories
Viral Inactivation Systems
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
3)Application
Vaccines and Therapeutics
Stem Cell Products
Cell Culture
Gene Therapy
Blood & Blood Products
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
4) End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before buying @ http://www.marketdataforecast.com/market-reports/latin-america-viral-inactivation-market-3233/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
Contact us
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
